Shape-shifting drug hits tumors in multiple ways, improves outcomes in mice.
New approach to designing drugs supercharges cancer medication (Links to an external site)
Shape-shifting drug hits tumors in multiple ways, improves outcomes in mice.
Cases climbed in Mexico, Peru and Puerto Rico over two decades, bucking a downward trend seen in many wealthy nations.
Founding members include WashU Medicine, pharmaceutical companies, philanthropic groups and others.
Earbud-like device from WashU startup Aurenar is designed to improve stroke outcomes after ruptured brain aneurysm.
Immune system aging linked to earlier lung cancer; fat tissue aging linked to earlier colorectal cancer.
The discovery could lead to a single vaccine against E. coli, Shigella and other causes of severe diarrhea.
Study finds the shot, currently in FDA review, could offer broader, longer-lasting protection.
Sleep, screen time, stress but not IQ also linked to children’s brain features.
Programs that analyze eye images could also speed up drug trials, study finds.
Bioengineered parasites could serve as long-term drug factories for hosts.